<DOC>
	<DOCNO>NCT01285674</DOCNO>
	<brief_summary>In study aim determine cisplatin ototoxicity prevent intratympanic administration corticosteroid .</brief_summary>
	<brief_title>Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin .</brief_title>
	<detailed_description>Cisplatin potent widely use antineoplastic drug . Ototoxicity serious dose-limiting side effect . The ototoxic effect cisplatin characterize irreversible , progressive , bilateral , high-frequency , sensorineural hearing loss tinnitus . 60-80 % patient treat show elevation hear threshold nearly 15 % sustain significant hearing handicap . There currently clinical intervention show prevent cisplatin ototoxicity human . Glucocorticoids significant potential otoprotection . Glucocorticoids use treatment variety cochlear disorder autoimmune inner ear disease , Meniere 's disease sudden sensorineural hearing loss . Intratympanic administration drug contemporary , safe method locally treat inner ear disorder , allow diffusion across round window inner ear . This method achieve much high steroid level within inner ear compare oral parenteral route . Local administration prevents common systemic side effect steroid . Previous animal study show protection cisplatin-induced ototoxicity intratympanic steroid injection . Asa far know , yet study human examine otoprotective effect intratympanic steroid patient treat cisplatin . In study aim determine cisplatin ototoxicity prevent intratympanic administration corticosteroid .</detailed_description>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>adult 18 year old least candidate Cisplatin treatment agreement participate study sign informed consent . refusal participate steroid treatment past month external middle ear disease enable intratympanic treatment inner ear disease cause hearing loss severe hearing loss reason conductive hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>cisplatin</keyword>
	<keyword>ototoxicity</keyword>
	<keyword>intratympanic steroid</keyword>
</DOC>